Neoadjuvant androgen deprivation therapy combined with abiraterone acetate in patients with locally advanced or metastatic prostate cancer: When to perform radical prostatectomy?

The surgical timing after neoadjuvant androgen‐deprivation therapy (ADT) plus abiraterone acetate (AA) for patients with locally advanced or metastatic prostate cancer (PCa) is unknown. We divided patients with locally advanced or metastatic PCa into three groups according to prostate‐specific antig...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ziyang, Wei, Fukun, Wang, Jie, Ma, Sai, Kan, Yi, Li, Bingheng, Qi, Nienie, Mao, Lijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
BRIEF COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972149/
https://www.ncbi.nlm.nih.gov/pubmed/36106643
http://dx.doi.org/10.1002/cam4.5255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972149/
https://www.ncbi.nlm.nih.gov/pubmed/36106643
http://dx.doi.org/10.1002/cam4.5255

Ejemplares similares